Form D · Biotechnology
Trojan Technologies USA, LLC
Palo Alto, CA · CIK 0001498334
Offering snapshot reported Aug 6, 2010 · SEC filing
- Reported sold
- Yet to sell Offering amount: $255K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2010 | Initial | Yet to sell | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-146010
Source: Form D, filed Aug 6, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Bailey | Director |
| Declan Doogan | Director |
| Agammemnon Epenetos | Director |
| John Micek | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
130 Lytton Avenue, Suite 210
Palo Alto, CA, 94301
Palo Alto, CA, 94301